- Home
- NIPG vs CNTX Comparison
NIPG vs CNTX Comparison
Compare NIPG & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIPG
- CNTX
- Stock Information
- Founded
- NIPG 2014
- CNTX 2015
- Country
- NIPG Sweden
- CNTX United States
- Employees
- NIPG N/A
- CNTX N/A
- Industry
- NIPG
- CNTX Biotechnology: Pharmaceutical Preparations
- Sector
- NIPG
- CNTX Health Care
- Exchange
- NIPG NYSE
- CNTX Nasdaq
- Market Cap
- NIPG 96.4M
- CNTX 78.0M
- IPO Year
- NIPG 2024
- CNTX 2021
- Fundamental
- Price
- NIPG $2.41
- CNTX $0.69
- Analyst Decision
- NIPG Strong Buy
- CNTX Strong Buy
- Analyst Count
- NIPG 1
- CNTX 5
- Target Price
- NIPG $6.00
- CNTX $5.50
- AVG Volume (30 Days)
- NIPG 406.8K
- CNTX 152.6K
- Earning Date
- NIPG 04-30-2025
- CNTX 08-06-2025
- Dividend Yield
- NIPG N/A
- CNTX N/A
- EPS Growth
- NIPG N/A
- CNTX N/A
- EPS
- NIPG N/A
- CNTX N/A
- Revenue
- NIPG $85,266,306.00
- CNTX N/A
- Revenue This Year
- NIPG $11.25
- CNTX N/A
- Revenue Next Year
- NIPG $33.33
- CNTX N/A
- P/E Ratio
- NIPG N/A
- CNTX N/A
- Revenue Growth
- NIPG 1.91
- CNTX N/A
- 52 Week Low
- NIPG $0.99
- CNTX $0.49
- 52 Week High
- NIPG $17.76
- CNTX $2.75
- Technical
- Relative Strength Index (RSI)
- NIPG N/A
- CNTX 57.14
- Support Level
- NIPG N/A
- CNTX $0.62
- Resistance Level
- NIPG N/A
- CNTX $0.67
- Average True Range (ATR)
- NIPG 0.00
- CNTX 0.05
- MACD
- NIPG 0.00
- CNTX 0.01
- Stochastic Oscillator
- NIPG 0.00
- CNTX 89.29
About NIPG NIP GROUP INC SPON ADS EACH REPR 2 CL A ORD SHS
NIP Group Inc is a digital entertainment company built for the growing gaming and esports industry. NIP Group integrates multiple businesses such as talent agency, event production, game-themed hotels and game publishing to create transformative entertainment experiences that inspire, connect fans, expand influence globally, and achieve deep interaction on platforms where digital native players gather. It currently has operation centers in Sweden, China, Abu Dhabi, and Brazil, and its esports teams cover multiple game projects and are active in the top event stages.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.